Norges Bank acquired a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 778,539 shares of the company's stock, valued at approximately $74,701,000. Norges Bank owned 0.90% of HealthEquity at the end of the most recent reporting period.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Arcadia Investment Management Corp MI purchased a new position in shares of HealthEquity in the 4th quarter valued at $26,000. Smartleaf Asset Management LLC boosted its position in HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Proficio Capital Partners LLC purchased a new position in HealthEquity in the fourth quarter valued at about $39,000. UMB Bank n.a. raised its holdings in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company's stock worth $40,000 after purchasing an additional 164 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ lifted its position in shares of HealthEquity by 1,934.8% during the fourth quarter. Skandinaviska Enskilda Banken AB publ now owns 468 shares of the company's stock valued at $45,000 after buying an additional 445 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.
HealthEquity Stock Performance
NASDAQ:HQY traded down $4.17 during trading hours on Friday, reaching $78.80. The company had a trading volume of 1,933,052 shares, compared to its average volume of 740,684. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The business's 50 day moving average price is $101.66 and its 200-day moving average price is $96.21. The firm has a market cap of $6.82 billion, a PE ratio of 72.29, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49.
Insider Activity at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 2.20% of the company's stock.
Analyst Ratings Changes
A number of brokerages have recently issued reports on HQY. JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Tuesday, December 10th. Royal Bank of Canada lifted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the stock an "outperform" rating in a report on Tuesday, December 10th. The Goldman Sachs Group decreased their price objective on HealthEquity from $107.00 to $94.00 and set a "neutral" rating for the company in a report on Thursday, March 27th. Barrington Research restated an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. Finally, Raymond James upgraded HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the company from $120.00 to $115.00 in a research note on Tuesday, March 25th. One analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of "Buy" and an average target price of $112.58.
Get Our Latest Analysis on HealthEquity
About HealthEquity
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
